Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications risk evaluation mitigation strategy assessments social science methodologies assess
… the SMDM 45th Annual North American Meeting. Can monetary risk preference explain health behavior and health …
… attributes that enable a more active lifestyle with lower risk of inhibitor development. Cano V, Mansfield C, Pierce A, …
Ravi Goyal Health Economics Telecommuter - USA PhD, Pharmaceutical Health Outcomes and Policy MS, Pharmacy Administration University of Houston, Houston, TX BPharm Rajiv Gandhi University of Technology, Madhya Pradesh, India Ravi Goyal, PhD, is a Senior …
… in the field of pharmacoepidemiology. His experience and publications span many therapeutic areas, including kidney …
Webinar: HEOR Evidence for Emergent Infectious Diseases Share on: Thursday, September 16, 2021 View Now Generating and communicating evidence in COVID-19 treatment and vaccine development Although COVID-19-related disruptions to the pharmaceutical supply …
About As a business unit of RTI International , we provide global biopharmaceutical companies research and consulting services in health economics, patient-centered outcomes research, market access, and pharmacoepidemiology. As the only non-profit, …
… applied Their overall role in developing a reimbursement strategy This short episode is ideal for those who are new to …
Chloe Seddon Medical Writing, Editing, and Design Services Manchester, United Kingdom PhD, Life Sciences MRes, Molecular & Cellular Life Sciences Imperial College London, London, United Kingdom MBio, Biochemistry University of Warwick, Coventry, United …
… - Their critical role in developing a reimbursement strategy for orphan drugs - How they are developed and …
… Group. RTI earned four out of five stars, based on evaluation in eight categories: company image, corporate …